ConductScience.org, home

Paper31392205

The role of patient advocacy organizations in shaping medical research: the Pompe model.

House T and 6 others. Ann Transl Med, 2019. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The role of patient advocacy organizations in shaping medical research: the Pompe model. Papers, record 31392205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31392205

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of patient advocacy organizations in shaping medical research: the Pompe model.
PubMed
Journal
Ann Transl Med
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2023-10-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1House TTiffany
2O'Donnell KKevin
3Saich RRaymond
4Di Pietro FFabio
5Broekgaarden RRia
6Muir AAllan
7Schaller TThomas

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126685070Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes.J Pediatr2016https://conductscience.org/library/papers/26685070PubMed
226768149Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study.J Inherit Metab Dis2016https://conductscience.org/library/papers/26768149PubMed
318519449Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.Pediatrics2008https://conductscience.org/library/papers/18519449PubMed
423632029Pompe disease: early diagnosis and early treatment make a difference.Pediatr Neonatol2013https://conductscience.org/library/papers/23632029PubMed
525617983Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.Neuromuscul Disord2015https://conductscience.org/library/papers/25617983PubMed
629155436Enzyme replacement therapy for infantile-onset Pompe disease.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29155436PubMed
724243590A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.Am J Med Genet A2014https://conductscience.org/library/papers/24243590PubMed
820404746Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease.J Neuroophthalmol2010https://conductscience.org/library/papers/20404746PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41332486Interactions Between Pharmaceutical Companies and Patient Advocacy Groups in Japan: A Qualitative and Quantitative Interview Study.Risk Manag Healthc Policy2025https://conductscience.org/library/papers/41332486PubMed
39253288Global hepatitis B and D community advisory board: expectations, challenges, and lessons learned.Front Public Health2024https://conductscience.org/library/papers/39253288PubMed
38987844A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem.Orphanet J Rare Dis2024https://conductscience.org/library/papers/38987844PubMed
38108236Building advocacy into research.Dis Model Mech2023https://conductscience.org/library/papers/38108236PubMed
34721018Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China.Front Pharmacol2021https://conductscience.org/library/papers/34721018PubMed
33073001Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective.Int J Neonatal Screen2020https://conductscience.org/library/papers/33073001PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31392205

GET https://conductscience.org/api/papers/v1/31392205/authors